HLA98-MiPS4F15
ESi092-A
General
Cell Line |
|
hPSCreg name | ESi092-A |
Cite as: | ESi092-A (RRID:CVCL_C6PU) |
Alternative name(s) |
HLA98-MiPS4F15
|
Cell line type | Human induced pluripotent stem cell (hiPSC) |
Similar lines | No similar lines found. |
Last update | 7th October 2022 |
User feedback | |
Provider |
|
Generator | Spanish Stem Cell Bank (ES) |
External Databases |
|
BioSamples | SAMEA111440892 |
Cellosaurus | CVCL_C6PU |
Wikidata | Q117704318 |
General Information |
|
* Is the cell line readily obtainable for third parties? |
No |
Donor Information
General Donor Information |
|
Sex | male |
Ethnicity | Caucasian |
Phenotype and Disease related information (Donor) |
|
Diseases | No disease was diagnosed.
|
Karyotyping (Donor) |
|
Has the donor karyotype been analysed? |
Yes
Karyotyping method:
G-Banding
|
Other Genotyping (Donor) |
|
Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
BioSamples | SAMEA111440893 |
Ethics
Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes |
Was the consent voluntarily given? | Yes |
Has the donor been informed that participation will not directly influence their personal treatment? | Yes |
Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes |
Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes |
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised |
Does consent explicitly allow the derivation of pluripotent stem cells? | Yes |
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No |
How may genetic information associated with the cell line be accessed? | Controlled Access |
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No |
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? | Yes |
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? | Yes |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes |
Name of accrediting authority involved? | Comité Coordinador de Etica de la Investigación Biomédica de Andalucía |
Approval number | 18/18/2015 |
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? | Yes |
Name of accrediting authority involved? | Comité Andaluz de Ética de Investigación con Muestras Biológicas de Naturaleza Embrionaria y otras Células Semejantes |
Approval number | PR-04-2015 |
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? |
hIPSC Derivation
General |
|
Source cell line name |
PBMC Derived from same source line (potentially other lot and donor, see below):
|
Source cell type |
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
|
Source cell origin |
1: The fluid that circulates in the heart, arteries, capillaries, and veins of a vertebrate animal carrying nourishment and oxygen to and bringing away waste products from all parts of the body. 2: A comparable fluid of an invertebrate.
Synonyms
|
Reprogramming method |
|
Vector type | Non-integrating |
Vector | Sendai virus |
Genes | |
Is reprogramming vector detectable? |
No |
Methods used |
RT-PCR
|
Notes on reprogramming vector detection | RT-PCR at passage 8 showed no presence of vector remnants |
Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming |
|
Other |
|
Selection criteria for clones | Clones were selected based on morphology |
Derived under xeno-free conditions |
Yes |
Derived under GMP? |
No |
Available as clinical grade? |
No |
Culture Conditions
Surface coating | Laminin |
Feeder cells |
No |
Passage method |
Enzymatically
TrypLE
|
O2 Concentration | 21 % |
CO2 Concentration | 21 % |
Medium |
mTeSR™ Plus
|
Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | Yes |
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | Yes |
Characterisation
Analysis of Undifferentiated Cells
Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles |
POU5F1 (OCT-4) |
Yes |
|||||
NANOG |
Yes |
|||||
SOX2 |
Yes |
|||||
SSEA-3 |
Yes |
|||||
SSEA-4 |
Yes |
|||||
TRA 1-60 |
Yes |
Differentiation Potency
In vitro spontaneous differentiation
Marker | Expressed |
AFP |
Yes |
Morphology
AFP_TrilineageDiff_HLA98-MiPS4F15.pdf
Microscope pictures showing immunofluorescence staining of AFP in spontaneously differentiated cultures
In vitro spontaneous differentiation
Marker | Expressed |
ACTA2 |
Yes |
Morphology
aSMA_TrilineageDiff_HLA98-MiPS4F15.pdf
Microscope pictures showing immunofluorescence staining of ACTA2 (aSMA) in spontaneously differentiated cultures
Morphology
PAX6_TrilineageDiff_HLA98-MiPS4F15.pdf
Microscope pictures showing immunofluorescence staining of PAX6 in spontaneously differentiated cultures
TUJ20_TrilineageDiff_HLA98-MiPS4F15.pdf
Microscope pictures showing immunofluorescence staining of Beta-III Tubulin (TUJ20) in spontaneously differentiated cultures
Microbiology / Virus Screening |
|
HIV 1 | Negative |
HIV 2 | Negative |
Hepatitis B | Negative |
Hepatitis C | Negative |
Mycoplasma | Negative |
Genotyping
Karyotyping (Cell Line) |
|
Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
Login to share your feedback, experiences or results with the research community.